Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- ACCEL Lite: The Role of Prevention During and After ReproductionIn this interview, Drs. Alison L. Bailey, MD, FACC and Ijeoma Isiadinso, MD, FACC discuss “The Role of Prevention During & After Reproductionâ€.
- Is Remnant Cholesterol an Independent CV Risk Factor in Young Adults?Most notably in young adults, high levels of remnant cholesterol (remnant-C) confer an independent risk of major adverse cardiovascular events (MACE), even those with optimal levels of LDL-C, and identification of high remnant-C levels at a young age may enhance preventive strategies, according to a study presented at the 17th Asian Pacific Society of Atherosclerosis […]
- Angiographic Control vs Ischemia-Driven Management of Patients Treated With PCI on Left Main With Drug-Eluting StentsIn the PULSE trial, CCTA following PCI for unprotected left main disease failed to reduce the composite primary endpoint of all-cause death, spontaneous MI, unstable angina, or definite or probable stent thrombosis.
- Olezarsen in Patients With Hypertriglyceridemia at High Cardiovascular RiskThe Essence-TIMI 73b trial demonstrated that olezarsen, compared with placebo, significantly reduced triglyceride levels in patients with moderate hypertriglyceridemia and elevated cardiovascular risk.
- ACC CardiaCast: Innovation in Action: AI-Enabled ECG: From Concept to Clinical CareIn this episode with Drs. Francisco Lopez-Jimenez and Paul Friedman, ACC Chief Innovation Officer Dr. Ami Bhatt explores the rapid rise of artificial intelligence (AI) tools in cardiovascular care, highlighting why screening tools such as the electrocardiogram (ECG) are particularly well-suited for innovation.